Calluna Pharma AS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis (NCT06736990) | Calluna Pharma AS | 2025-06-20 |
Track Calluna Pharma AS automatically
Every clearance here is in the API, with alerts when new ones post.